| Year |
Citation |
Score |
| 2019 |
Abecassis I, Sedgewick AJ, Romkes M, Buch S, Nukui T, Kapetanaki MG, Vogt A, Kirkwood JM, Benos PV, Tawbi H. PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy. Scientific Reports. 9: 3309. PMID 30824778 DOI: 10.1038/S41598-019-39542-2 |
0.399 |
|
| 2015 |
Siegfried JM, Lin Y, Diergaarde B, Lin HM, Dacic S, Pennathur A, Weissfeld JL, Romkes M, Nukui T, Stabile LP. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome. Neoplasia (New York, N.Y.). 17: 817-25. PMID 26678909 DOI: 10.1016/J.Neo.2015.11.002 |
0.422 |
|
| 2015 |
Weissfeld JL, Lin Y, Lin HM, Kurland BF, Wilson DO, Fuhrman CR, Pennathur A, Romkes M, Nukui T, Yuan JM, Siegfried JM, Diergaarde B. Lung cancer risk prediction using common SNPs located in GWAS-identified susceptibility regions. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26352532 DOI: 10.1097/Jto.0000000000000666 |
0.401 |
|
| 2015 |
Leng S, Liu Y, Weissfeld JL, Thomas CL, Han Y, Picchi MA, Edlund CK, Willink RP, Gaither Davis AL, Do KC, Nukui T, Zhang X, Burki EA, Van Den Berg D, Romkes M, et al. 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers. Journal of the National Cancer Institute. 107. PMID 25713168 DOI: 10.1093/Jnci/Djv035 |
0.409 |
|
| 2015 |
Fung C, Zhou P, Joyce S, Trent K, Yuan JM, Grandis JR, Weissfeld JL, Romkes M, Weeks DE, Egloff AM. Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma. Cancer Letters. 357: 549-56. PMID 25511740 DOI: 10.1016/J.Canlet.2014.12.008 |
0.37 |
|
| 2015 |
Sheth S, Weissfeld JL, Romkes M, Ferris RL, Grandis JR, Bauman JE, Diergaarde B. Germline variation in NFE2L2/CUL3/KEAP1 and risk of head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 33: 1540-1540. DOI: 10.1200/Jco.2015.33.15_Suppl.1540 |
0.37 |
|
| 2015 |
Stabile LP, Rothenberger NJ, Romkes M, Koodie L, Farooqui M, Dacic S, Siegfried JM. Abstract 1861: Estrogen modulation of fibroblast growth factor signaling in non-small cell lung cancer Cancer Research. 75: 1861-1861. DOI: 10.1158/1538-7445.Am2015-1861 |
0.375 |
|
| 2014 |
Yu G, Herazo-Maya JD, Nukui T, Romkes M, Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM, Kaminski N, Kass DJ. Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine. 190: 780-90. PMID 25250855 DOI: 10.1164/Rccm.201310-1903Oc |
0.352 |
|
| 2014 |
Weissfeld JL, Diergaarde B, Nukui T, Buch S, Pennathur A, Socinski MA, Siegfried JM, Romkes M. Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1264-71. PMID 25122423 DOI: 10.1097/Jto.0000000000000262 |
0.363 |
|
| 2014 |
Romkes M, Buch SC. Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening. Methods in Molecular Biology (Clifton, N.J.). 1105: 99-115. PMID 24623222 DOI: 10.1007/978-1-62703-739-6_8 |
0.311 |
|
| 2014 |
Siegfried J, Lin Y, Dacic S, Stabile L, Diergaarde B, Lin H, Nukui T, Romkes M. Prediction of NSCLC Survival With the PAM50 Breast Cancer Signature International Journal of Radiation Oncology*Biology*Physics. 90: S71-S72. DOI: 10.1016/J.Ijrobp.2014.08.306 |
0.309 |
|
| 2013 |
Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, Freilino M, Sauerwein S, Peyser ND, Xiao D, Diergaarde B, ... ... Romkes M, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discovery. 3: 761-9. PMID 23619167 DOI: 10.1158/2159-8290.Cd-13-0103 |
0.319 |
|
| 2013 |
Troy JD, Grandis JR, Youk AO, Diergaarde B, Romkes M, Weissfeld JL. Childhood passive smoke exposure is associated with adult head and neck cancer. Cancer Epidemiology. 37: 417-23. PMID 23619143 DOI: 10.1016/J.Canep.2013.03.011 |
0.344 |
|
| 2013 |
Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL. Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors. Cancer Epidemiology. 37: 518-22. PMID 23619141 DOI: 10.1016/J.Canep.2013.03.020 |
0.372 |
|
| 2013 |
Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer. Substance Use & Misuse. 48: 490-4. PMID 23528144 DOI: 10.3109/10826084.2013.778280 |
0.323 |
|
| 2013 |
Troy JD, Weissfeld JL, Diergaarde B, Youk AO, Buch SC, Romkes M, Grandis JR. Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer. Cancer Epidemiology. 37: 505-11. PMID 23523331 DOI: 10.1016/J.Canep.2013.02.009 |
0.391 |
|
| 2013 |
Fung C, Trent K, Joyce S, Zhou P, Nukui T, Weeks DE, Diergaarde B, Ye Y, Wu X, Yuan J, Grandis J, Weissfeld JL, Romkes M, Egloff AM. Abstract 1340: Identification of epidermal growth factor receptor (EGFR) polymorphisms that modify risk for squamous cell carcinoma of the head and neck (HNSCC). Cancer Research. 73: 1340-1340. DOI: 10.1158/1538-7445.Am2013-1340 |
0.389 |
|
| 2012 |
Buch SC, Diergaarde B, Nukui T, Day RS, Siegfried JM, Romkes M, Weissfeld JL. Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer. Molecular Carcinogenesis. 51: E11-20. PMID 21976407 DOI: 10.1002/Mc.20858 |
0.456 |
|
| 2012 |
Krauze MT, Hamilton RH, Romkes M, Bortoluzzi S, Harasymczuk M, Reinhard T, Junecko BF, Nukui T, Konstantinopoulos P, Becker D, Kondziolka D, Tarhini AA, Whiteside T, Mintz AH, Tawbi H, et al. Association of high T-cell immune infiltrate and low hemorrhage in melanoma brain metastases (MBMs) with prolonged survival. Journal of Clinical Oncology. 30: 8528-8528. DOI: 10.1200/Jco.2012.30.15_Suppl.8528 |
0.322 |
|
| 2012 |
Pancoska P, Romkes M, Nukui T, Buch S, Herazo-Maya J, Kaminski N, Dacic S, Weissfeld JL, Bigbee WL, Siegfried JM. Abstract 4937: Factors in NSCLC stage and outcome: Integrated genome-wide study Cancer Research. 72: 4937-4937. DOI: 10.1158/1538-7445.Am2012-4937 |
0.345 |
|
| 2012 |
Romkes M, Nukui T, Buch S, Pancoska P, Herazo-Maya J, Kaminski N, Dacic S, Weissfeld JL, Bigbee WL, Shapiro SD, Siegfried JM. Abstract 1722: Prognostic markers in early stage non small-cell lung cancer (NSCLC) Cancer Research. 72: 1722-1722. DOI: 10.1158/1538-7445.Am2012-1722 |
0.401 |
|
| 2012 |
Pancoska P, Romkes M, Nukui T, Buch S, Herazo-Maya J, Kaminski N, Dacic S, Weissfeld JL, Bigbee WL, Shapiro SD, Siegfried JM. Abstract 1720: Validation of a 15-gene prognostic signature in stage IB non small-cell lung cancer (NSCLC) Cancer Research. 72: 1720-1720. DOI: 10.1158/1538-7445.Am2012-1720 |
0.374 |
|
| 2011 |
Zhong S, Nukui T, Buch S, Diergaarde B, Weissfeld LA, Grandis J, Romkes M, Weissfeld JL. Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2429-37. PMID 21890746 DOI: 10.1158/1055-9965.Epi-11-0520 |
0.328 |
|
| 2011 |
Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, ... ... Romkes M, et al. The mutational landscape of head and neck squamous cell carcinoma. Science (New York, N.Y.). 333: 1157-60. PMID 21798893 DOI: 10.1126/Science.1208130 |
0.307 |
|
| 2011 |
Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, ... ... Romkes M, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. Journal of the National Cancer Institute. 103: 817-25. PMID 21483023 DOI: 10.1093/Jnci/Djr075 |
0.385 |
|
| 2011 |
McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Bencko V, Holcatova I, ... ... Romkes M, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. Plos Genetics. 7: e1001333. PMID 21437268 DOI: 10.1371/Journal.Pgen.1001333 |
0.415 |
|
| 2011 |
Chen D, Truong T, Gaborieau V, Byrnes G, Chabrier A, Chuang SC, Olshan AF, Weissler MC, Luo J, Romkes M, Buch S, Nukui T, Franceschi S, Herrero R, Talamini R, et al. A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 658-64. PMID 21335511 DOI: 10.1158/1055-9965.Epi-10-1008 |
0.413 |
|
| 2010 |
Gao W, Romkes M, Zhong S, Nukui T, Persad RA, Smith PJ, Branch R, Keohavong P. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncology Reports. 24: 257-62. PMID 20514470 DOI: 10.3892/Or_00000854 |
0.439 |
|
| 2010 |
Vaezi AE, Wang X, Buch SC, Farrow D, Weaver DT, D'Andrea AD, Seethala RR, Romkes M, Niedernhofer LJ, Grandis JR. Use of XPF expression in tumors and XPF single nucleotide polymorphisms to predict clinical outcome in head and neck cancer. Journal of Clinical Oncology. 28: 5520-5520. DOI: 10.1200/Jco.2010.28.15_Suppl.5520 |
0.322 |
|
| 2010 |
Brenda D, Buch S, Nukui T, Day R, Siegfried J, Weissfeld J, Romkes M. Abstract LB-414: Variation in base excision repair genes and risk of smoking-related non-small cell lung cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-414 |
0.417 |
|
| 2010 |
Buch SC, Nukui T, Weissfeld J, Romkes M. Abstract 1868: Evaluation of the nucleotide excision repair polymorphisms for association with lung cancer risk Cancer Research. 70: 1868-1868. DOI: 10.1158/1538-7445.Am10-1868 |
0.453 |
|
| 2010 |
Nukui T, Pancoska P, Buch S, Ramirez JL, Taron M, Rosell R, Romkes M. Abstract 147: DNA methylation patterns are associated with cisplatin and docetaxel response and survival among NSCLC cases Cancer Research. 70: 147-147. DOI: 10.1158/1538-7445.Am10-147 |
0.35 |
|
| 2009 |
Tawbi HA, Buch S, Pancoska P, Lin Y, Saul M, Romkes M, Sobol R, Kirkwood JM. Prediction of response to alkylator-based chemotherapy in metastatic melanoma (MM) using gene expression and promoter methylation signatures. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9009. PMID 27962356 DOI: 10.1200/Jco.2009.27.15_Suppl.9009 |
0.319 |
|
| 2009 |
Romkes M, Feinstein TM, Zhong S, Buch S, Gibson MK, Skovira K, Argiris A. TS and MTHFR gene polymorphisms in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head or neck (SCCHN) treated with pemetrexed (P) and bevacizumab (B). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e17011. PMID 27961740 DOI: 10.1200/Jco.2009.27.15_Suppl.E17011 |
0.339 |
|
| 2009 |
Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL. Smoking behavior 1 year after computed tomography screening for lung cancer: Effect of physician referral for abnormal CT findings. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3484-9. PMID 19959699 DOI: 10.1158/1055-9965.Epi-09-0895 |
0.334 |
|
| 2009 |
Styn MA, Nukui T, Romkes M, Perkins K, Land SR, Weissfeld JL. The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 254-61. PMID 18563706 DOI: 10.1002/Ajmg.B.30801 |
0.339 |
|
| 2008 |
Buch SC, Nazar-Stewart V, Weissfeld JL, Romkes M. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head & Neck. 30: 1139-47. PMID 18642288 DOI: 10.1002/Hed.20867 |
0.441 |
|
| 2008 |
Romkes M, Landreneau RJ, Schuchert MJ, Buch SC, Luketich JD, Siegfried JM. Use of ERCC1 polymorphism and extreme drug resistance assay to predict overall non-small cell lung cancer survival and responsiveness to platinum-based chemotherapy agents Journal of Clinical Oncology. 26: 8092-8092. DOI: 10.1200/Jco.2008.26.15_Suppl.8092 |
0.383 |
|
| 2007 |
Zhang W, Weissfeld JL, Romkes M, Land SR, Grandis JR, Siegfried JM. Association of the EGFR intron 1 CA repeat length with lung cancer risk. Molecular Carcinogenesis. 46: 372-80. PMID 17219440 DOI: 10.1002/Mc.20285 |
0.393 |
|
| 2007 |
Ayres B, Buch B, Kondragunta V, Gillatt D, Romkes M, Branch R, Persad R. MP-19.13: CYP3A mediated dapsone recovery ratio may predict tumour progression in superficial bladder cancer Urology. 70: 147-148. DOI: 10.1016/J.Urology.2007.06.548 |
0.33 |
|
| 2006 |
Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, ... ... Romkes M, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. American Journal of Epidemiology. 164: 1027-42. PMID 17000715 DOI: 10.1093/Aje/Kwj321 |
0.452 |
|
| 2006 |
Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers. Molecular Carcinogenesis. 45: 828-32. PMID 16865671 DOI: 10.1002/Mc.20208 |
0.413 |
|
| 2006 |
Nukui T, Day RD, Gordish-Dressman HA, Harger G, Bigbee WL, Ness RB, Romkes M. The absence of interaction between drug metabolizing enzyme genotypes and maternal lifestyle factors on glycophorin A somatic mutation frequency levels in newborns. Pharmacogenetics and Genomics. 16: 129-38. PMID 16424825 DOI: 10.1097/01.Fpc.0000184954.08453.E1 |
0.33 |
|
| 2006 |
Zhang W, Stabile LP, Keohavong P, Romkes M, Grandis JR, Traynor AM, Siegfried JM. Mutation and Polymorphism in the EGFR-TK Domain Associated with Lung Cancer Journal of Thoracic Oncology. 1: 635-647. DOI: 10.1016/S1556-0864(15)30375-0 |
0.356 |
|
| 2005 |
Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, ... ... Romkes M, et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutation Research. 592: 45-57. PMID 16009381 DOI: 10.1016/J.Mrfmmm.2005.06.002 |
0.463 |
|
| 2005 |
Buch S, Zhu B, Davis AG, Odom D, Siegfried JM, Grandis JR, Romkes M. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract. Molecular Carcinogenesis. 42: 222-8. PMID 15754315 DOI: 10.1002/Mc.20086 |
0.42 |
|
| 2005 |
Branch RA, Paulsen N, Persad RA, Smith PJB, Collins C, Schwartz A, Cecchetti A, Arena VC, Jones K, Romkes M. Genetic susceptibility to risk for bladder cancer in individuals working in high risk occupations Current Pharmacogenomics. 3: 165-175. DOI: 10.2174/1570160054864049 |
0.372 |
|
| 2004 |
Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, et al. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 9: 298-305. PMID 15764294 DOI: 10.1080/13547500400011070 |
0.432 |
|
| 2004 |
Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, ... ... Romkes M, et al. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. International Journal of Cancer. Journal International Du Cancer. 110: 266-70. PMID 15069692 DOI: 10.1002/Ijc.20114 |
0.377 |
|
| 2003 |
Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis. 24: 1671-6. PMID 12844488 DOI: 10.1093/Carcin/Bgg115 |
0.422 |
|
| 2003 |
Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis. 24: 875-82. PMID 12771031 DOI: 10.1093/Carcin/Bgg026 |
0.397 |
|
| 2003 |
Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Kalina I, Kremers P, Le Marchand L, ... ... Romkes M, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. International Journal of Epidemiology. 32: 60-3. PMID 12690010 DOI: 10.1093/Ije/Dyg001 |
0.449 |
|
| 2003 |
Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, ... ... Romkes M, et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. International Journal of Cancer. 104: 650-7. PMID 12594823 DOI: 10.1002/Ijc.10995 |
0.459 |
|
| 2003 |
Siegfried JM, Stabile L, Lerdtragool S, Romkes M. E-73.Hormones - do they make a difference in lung cancer? Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)90480-6 |
0.338 |
|
| 2002 |
Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmöller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, ... ... Romkes M, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 23: 1343-50. PMID 12151353 DOI: 10.1093/Carcin/23.8.1343 |
0.455 |
|
| 2002 |
Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmöller J, Daly AK, Heckbert SR, Kalina I, ... ... Romkes M, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. American Journal of Epidemiology. 156: 95-109. PMID 12117698 DOI: 10.1093/Aje/Kwf018 |
0.42 |
|
| 1997 |
Persad R, Fleming C, Chern HD, Lesnick T, Collins C, Smith P, Schwartz AG, Adedoyin A, Romkes M, Wilkinson GR, Branch RA. Environmental procarcinogen hypothesis of bladder cancer in humans: Dapsone hydroxylation as a susceptibility risk factor for aggressive bladder cancer. Urologic Oncology. 3: 18-26. PMID 21227048 DOI: 10.1016/S1078-1439(97)00019-7 |
0.387 |
|
| 1996 |
Romkes M, Chern HD, Lesnick TG, Becich MJ, Persad R, Smith P, Branch RA. Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer. Carcinogenesis. 17: 1057-62. PMID 8640913 DOI: 10.1093/Carcin/17.5.1057 |
0.366 |
|
| 1996 |
Chern H, Becich MJ, Persad RA, Romkes M, Smith P, Collins C, Li Y, Branch RA. Clonal Analysis Of Human Recurrent Superficial Bladder Cancer By Immunohistochemistry Of P53 And Retinoblastoma Proteins The Journal of Urology. 156: 1846-1849. DOI: 10.1016/S0022-5347(01)65550-2 |
0.358 |
|
| Show low-probability matches. |